Filter by: Subject

Filter by: Subject

Results Per Page:

Tuberculosis (TB) (143)
Human immunodeficiency virus (HIV) (42)
South Africa (SA) (35)
Mycobacterium tuberculosis (MTB) (23)
Multidrug-resistant (MDR) (12)
Antiretroviral therapy (ART) (7)
Drug resistance (7)
Infection (7)
Coronavirus disease 2019 (COVID-19) (6)
COVID-19 pandemic (6)
Healthcare workers (HCWs) (6)
Mycobacterium tuberculosis (6)
SDG-03: Good health and well-being (6)
Treatment (6)
Multidrug-resistant tuberculosis (MDR-TB) (5)
Acquired immune deficiency syndrome (AIDS) (4)
Bedaquiline (4)
Extensively drug-resistant tuberculosis (XDR-TB) (4)
Patients (4)
Whole genome sequencing (WGS) (4)
Antibiotics (3)
Children (3)
Comorbidity (3)
Diagnosis (3)
Minimum inhibitory concentration (MIC) (3)
Mortality (3)
Multi-drug resistant tuberculosis (MDR-TB) (3)
Occupational health (3)
Public health (3)
Tobacco (3)
Transmission (3)
Treatment outcome (3)
Tuberculosis -- Treatment -- South Africa (3)
UCTD (3)
18F-FDG PET/CT (2)
Abdominal lymphadenopathy (2)
Adherence (2)
Adults (2)
Africa (2)
Alcohol use (2)
Antimicrobial resistance (AMR) (2)
Antiretroviral treatment (ART) (2)
Antitubercular drugs (2)
Catecholamines (2)
Clofazimine (CFZ) (2)
Cluster randomized controlled trial (2)
Colistin methanesulfonate (2)
Drug development (2)
Drug susceptibility testing (DST) (2)
Drug-resistant tuberculosis (2)
Drug-resistant tuberculosis (DR-TB) (2)
Endoscopic ultrasound (2)
Epidemics (2)
Ethiopia (2)
Gene mutation (2)
Growth (2)
Health services (2)
HIV/AIDS (2)
Implementation (2)
KwaZulu-Natal (KZN) (2)
KwaZulu-Natal, South Africa (2)
Loss to follow-up (LTFU) (2)
Low- and middle-income countries (LMICs) (2)
Lung cancer (2)
MDR-TB (2)
Medication adherence (2)
Meta-analysis (2)
Metabolomics (2)
Molecular docking (2)
Molecular dynamics (2)
Molecular epidemiology (2)
Motivational interviewing (2)
Moxifloxacin (2)
Mpumalanga province, South Africa (2)
Mutation (2)
Platelets (2)
Polymerase chain reaction (2)
Positron emission tomography (PET) (2)
Primary healthcare (PHC) (2)
Pulmonary tuberculosis (PTB) (2)
Randomized controlled trial (2)
Rifampicin (2)
Rifampicin-resistant tuberculosis (2)
Risk (2)
Risk factors (2)
Routine data (2)
Screening (2)
Single nucleotide polymorphism (2)
Smoking (2)
South African patients (2)
Tobacco cessation (2)
Traditional health practitioners (THPs) (2)
Treatment outcomes (2)
Tuberculosis -- Treatment (2)
Tuberculosis transmission (2)
Virtual screening (2)
Whole-genome sequencing (WGS) (2)
Xpert® MTB/RIF (2)
2-Fluorodeoxy-D-glucose imaging (1)
68Ga-citrate (1)